CalciMedicas Breakthrough Treatment Offers Hope for Acute Pancreatitis Patients
CalciMedica Inc, a clinical-stage biopharmaceutical company specializing in the development of novel calcium release-activated calcium (CRAC) channel inhibitors, is making significant strides in the field of acute pancr...
Jun 30, 2024
• Major Pharmaceutical Preparations Industry
Stocks on the Move
For Phase I Inc Healthcare Thursday Inc Calcimedi